What is CJC-1295 DAC? CJC-1295 with DAC is a long-acting growth-hormone-releasing hormone (GHRH) analogue studied for its effects on growth-hormone and downstream IGF-1 signaling. Research Areas GHRH receptor signaling Growth-hormone release IGF-1 signaling Endocrine research Body-composition research Recovery-related research Why is it being researched? The DAC component is designed to extend the compound's activity compared with shorter-acting GHRH analogues. Research has focused on how sustained GHRH signaling influences growth-hormone and IGF-1 pathways. PRIMAL RESEARCH NOTE: CJC-1295 remains a research compound and should not be presented as an approved treatment